Archives
-
Palonosetron for Preventing Chemotherapy-Induced Nausea
2026-09-10
Ruhlmann and Herrstedt review palonosetron hydrochloride as a long-acting 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting, emphasizing its high receptor affinity, allosteric binding, and potential advantages in delayed symptom control. The review also shows why pharmacologic distinctions must be judged against comparative clinical outcomes, tolerability, and the broader antiemetic regimen.
-
Aurora A in High-Risk Retinoblastoma
2026-09-10
A 2024 American Journal of Pathology study found that Aurora kinase A is frequently overexpressed in retinoblastoma and associated with histopathologic features linked to poor outcome and chemotherapy resistance. By combining patient-tissue profiling with genetic depletion, pharmacologic inhibition, patient-derived models, and xenografts, the work supports AURKA as a functionally relevant target while highlighting the need for disease-specific validation and ocular delivery studies.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-09-09
Phosphatase Inhibitor Cocktail (SKU K1015) helps limit post-lysis dephosphorylation during protein extraction and downstream phosphorylation assays. It is intended for research workflows such as immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry, not diagnostic or medical use.
-
Trichostatin A (TSA): Practical Cell Assay Guide
2026-09-09
Trichostatin A (TSA) provides a reversible HDAC-inhibition tool for studying histone acetylation, cell-cycle responses, differentiation, and cancer-cell phenotypes. It is intended for controlled in vitro and preclinical research workflows, not clinical treatment or direct potency comparisons across cell models without assay-specific optimization.
-
Thiothixene for Macrophage Efferocytosis Research
2026-09-08
Thiothixene is a typical antipsychotic agent that can serve as a practical bridge between dopamine signaling pathway modulation and macrophage clearance biology. This guide translates its reported 2 μM in vitro use into assay design, controls, troubleshooting, and appropriately bounded connections to emerging schizophrenia treatment research.
-
Nuclear mTORC1: TerminaTOR Maps Transcriptional Control
2026-09-08
Zhong and colleagues developed TerminaTOR, a genetically encodable inhibitor that selectively perturbs mTORC1 at defined subcellular locations. Their results distinguish lysosomal mTORC1 functions in autophagy from nuclear mTORC1 control of CCAAT motif-containing gene transcription, providing a framework for studying spatially compartmentalized signaling.
-
Dihydrotestosterone (DHT): Assay Design Guide
2026-09-07
This scenario-based guide explains how Dihydrotestosterone (DHT), SKU B8214, can support reproducible androgen receptor, viability, proliferation, and signaling experiments. It covers solvent compatibility, dose selection, pathway-aware interpretation, cross-model limitations, and practical supplier evaluation.
-
(-)-JQ1 in BET Control and AML Assay Design
2026-09-07
Discover how (-)-JQ1, the inactive JQ1 stereoisomer, strengthens BET inhibitor controls and clarifies transcriptional experiments inspired by the N-MYC/eIF4G1 axis in inv(16) AML.
-
ISRIB (trans-isomer): Memory Retention & ISR
2026-09-05
ISRIB (trans-isomer) is a brain-penetrant integrated stress response inhibitor with unusual value for separating memory retention from retrieval. This article translates recent epilepsy-associated forgetting research into practical assay logic for ER stress research, molecular validation, and cognitive models.
-
PD98059: Reading ERK Causality in Cell Injury
2026-09-04
PD98059 is a reversible MEK inhibitor that helps researchers distinguish ERK-dependent signaling from downstream oxidative and mitochondrial injury. This mechanistic guide uses hepatotoxicity research to refine assay design beyond standard proliferation and apoptosis workflows.
-
Red Blood Cell Lysis Buffer for Bone Research
2026-09-04
Turn crowded mammalian blood and tissue suspensions into cleaner, more reproducible inputs for flow cytometry, nucleic acid, protein, and cell-culture workflows. This guide shows how selective erythrocyte removal can support bone and immunology studies while preserving nucleated-cell quality.
-
Ampicillin sodium: Assay Workflows & Troubleshooting
2026-09-03
Build more reproducible antibacterial activity assays with a defined β-lactam mechanism, controlled dilution design, and stability-aware handling. This guide also shows how resistant-strain comparisons and recombinant selection workflows can extend the value of Ampicillin sodium beyond a single MIC endpoint.
-
TBK1, Microglia Pyroptosis, and Painful Diabetic Neuropathy
2026-09-03
Liao et al. identify TANK-binding kinase 1 (TBK1) as an upstream driver of painful diabetic neuropathy through activation of NF-κB, the NLRP3 inflammasome, and microglial pyroptosis. The study combines genetic, pharmacological, behavioral, vascular, and tissue-level analyses to support TBK1 inhibition as a mechanistically informed strategy for reducing diabetic pain and peripheral nerve injury.
-
Cannabidiol, Endocannabinoids, and Orofacial Pain
2026-09-02
This mouse study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive deficits through coordinated peripheral and central mechanisms. Its combination of behavioral profiling, molecular assays, and fiber photometry links FAAH–anandamide signaling with CB2-, CB1-, and serotonergic pathways, while also highlighting important limits for translation to human pain treatment.
-
MG-132 for Reliable Cell Viability Assays
2026-09-02
MG-132 (Z-LLL-al, SKU A2585) provides a practical, mechanism-based way to connect proteasome inhibition with apoptosis, cell-cycle arrest, and oxidative stress measurements. This scenario-driven guide explains dose selection, solvent handling, interpretation of viability data, and criteria for choosing a dependable research reagent.